Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04537819Completed
Randomised, open-label trial of Imupret in acute tonsillitis (2 arms), sponsored by Ivano-Frankivsk National Medical University. Primary endpoint: Changes in the severity of each symptom (complaint) at Day 28. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04537819.